Skip to main content
Top
Published in: Infection 6/2014

01-12-2014 | Original Paper

Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients

Authors: M. Papadimitriou-Olivgeris, E. Drougka, F. Fligou, F. Kolonitsiou, A. Liakopoulos, V. Dodou, E. D. Anastassiou, E. Petinaki, M. Marangos, K. S. Filos, I. Spiliopoulou

Published in: Infection | Issue 6/2014

Login to get access

Abstract

Purpose

Vancomycin-Resistant Enterococci (VRE) are important causes of Intensive Care Unit (ICU) infections. Our goal was to identify the prevalence and risk factors for VRE colonization upon ICU admission and during ICU stay, as well as, their impact in enterococcal infection including vancomycin-susceptible cases (VSE).

Methods

A prospective study regarding patients admitted in ICU (n = 497) was conducted during a 24-month period. Rectal swabs were collected upon admission and during hospitalization and inoculated onto selective medium. Enterococci were phenotypically characterized. van genes were investigated by PCR and clones were identified by Pulsed-Field Gel Electrophoresis and Multilocus Sequence Typing. Epidemiologic data were collected from the ICU database.

Results

Risk factors for VRE carriage upon ICU admission (71/497) were: duration of previous hospitalization, glycopeptide administration, chronic heart failure, malignancy, insulin-dependent diabetes mellitus, and previous enterococcal infection (VRE and/or VSE). Risk factors for VRE colonization during ICU stay (36/250) were: quinolone administration, chronic obstructive pulmonary disease, chronic renal failure, and number of VRE-positive patients in nearby beds. Risk factors for enterococcal infection during ICU stay (15/284), including VRE and VSE cases, were: administration of third- or fourth-generation cephalosporins, cortisone use before ICU admission and VRE colonization, whereas, enteral nutrition was a protective factor.

Conclusions

Previous VRE colonization and antibiotic usage are essential parameters for enterococcal infection (by VRE or VSE) during ICU stay. Previous enterococcal infection, co-morbidities and antibiotic usage are associated with VRE colonization upon ICU admission, whereas, patient to patient transmission, co-morbidities and antibiotic usage constitute risk factors for VRE colonization during ICU hospitalization.
Literature
1.
go back to reference Cattoir V, Leclercq R. Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? J Antimicrob Chemother. 2013;68:731–42.PubMedCrossRef Cattoir V, Leclercq R. Twenty-five years of shared life with vancomycin-resistant enterococci: is it time to divorce? J Antimicrob Chemother. 2013;68:731–42.PubMedCrossRef
2.
go back to reference European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report, Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Stockholm: ECDC; 2013. p. 2013. European Centre for Disease Prevention and Control (ECDC). Annual Epidemiological Report, Reporting on 2011 surveillance data and 2012 epidemic intelligence data. Stockholm: ECDC; 2013. p. 2013.
3.
go back to reference Werner G, Coque TM, Hammerum AM, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 2008;13. Werner G, Coque TM, Hammerum AM, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 2008;13.
4.
go back to reference Damani A, Klapsa D, Panopoulou M, et al. A newly described vancomycin-resistant ST412 Enterococcus faecium predominant in Greek hospitals. Eur J Clin Microbiol Infect Dis. 2010;29:329–31.PubMedCrossRef Damani A, Klapsa D, Panopoulou M, et al. A newly described vancomycin-resistant ST412 Enterococcus faecium predominant in Greek hospitals. Eur J Clin Microbiol Infect Dis. 2010;29:329–31.PubMedCrossRef
5.
go back to reference Sofianou D, Pournaras S, Giosi M, et al. Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. J Antimicrob Chemother. 2004;54:251–4.PubMedCrossRef Sofianou D, Pournaras S, Giosi M, et al. Substantially increased faecal carriage of vancomycin-resistant enterococci in a tertiary Greek hospital after a 4 year time interval. J Antimicrob Chemother. 2004;54:251–4.PubMedCrossRef
6.
go back to reference Kim YJ, Kim SI, Kim YR, et al. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. Am J Infect Control. 2012;40:1018–9.PubMedCrossRef Kim YJ, Kim SI, Kim YR, et al. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. Am J Infect Control. 2012;40:1018–9.PubMedCrossRef
7.
go back to reference Ostrowsky BE, Venkataraman L, D’Agata EM, et al. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med. 1999;159:1467–72.PubMedCrossRef Ostrowsky BE, Venkataraman L, D’Agata EM, et al. Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period. Arch Intern Med. 1999;159:1467–72.PubMedCrossRef
8.
go back to reference Song JY, Cheong HJ, Jo YM, et al. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control. 2009;37:734–40.PubMedCrossRef Song JY, Cheong HJ, Jo YM, et al. Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control. 2009;37:734–40.PubMedCrossRef
10.
go back to reference Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M7-A7. 12th ed. Wayne: CLSI; 2011. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, Approved standard M7-A7. 12th ed. Wayne: CLSI; 2011.
11.
go back to reference Bell J, Turnidge J, Coombs G, O’Brien F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell. 1998;22:249–52.PubMed Bell J, Turnidge J, Coombs G, O’Brien F. Emergence and epidemiology of vancomycin-resistant enterococci in Australia. Commun Dis Intell. 1998;22:249–52.PubMed
12.
go back to reference Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMedCentralPubMed Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–9.PubMedCentralPubMed
13.
go back to reference Christidou A, Gikas A, Scoulica E, et al. Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation. Clin Microbiol Infect. 2004;10:999–1005.PubMedCrossRef Christidou A, Gikas A, Scoulica E, et al. Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation. Clin Microbiol Infect. 2004;10:999–1005.PubMedCrossRef
14.
go back to reference Kolar M, Pantucek R, Vagnerova I, et al. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. New Microbiol. 2006;29:121–5.PubMed Kolar M, Pantucek R, Vagnerova I, et al. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic. New Microbiol. 2006;29:121–5.PubMed
15.
go back to reference Endtz HP, Van Den Braak N, Van Belkum A, et al. Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol. 1998;36:592–4.PubMedCentralPubMed Endtz HP, Van Den Braak N, Van Belkum A, et al. Comparison of eight methods to detect vancomycin resistance in enterococci. J Clin Microbiol. 1998;36:592–4.PubMedCentralPubMed
16.
go back to reference Beltrami EM, Singer DA, Fish L, et al. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control. 2000;28:282–5.PubMedCrossRef Beltrami EM, Singer DA, Fish L, et al. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control. 2000;28:282–5.PubMedCrossRef
17.
go back to reference Batistao DW, Gontijo-Filho PP, Conceicao N, et al. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012;107:57–63.PubMedCrossRef Batistao DW, Gontijo-Filho PP, Conceicao N, et al. Risk factors for vancomycin-resistant enterococci colonisation in critically ill patients. Mem Inst Oswaldo Cruz. 2012;107:57–63.PubMedCrossRef
18.
go back to reference Goetz AM, Rihs JD, Wagener MM, et al. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. Am J Infect Control. 1998;26:558–62.PubMedCrossRef Goetz AM, Rihs JD, Wagener MM, et al. Infection and colonization with vancomycin-resistant Enterococcus faecium in an acute care Veterans Affairs Medical Center: a 2-year survey. Am J Infect Control. 1998;26:558–62.PubMedCrossRef
19.
go back to reference MacIntyre CR, Empson M, Boardman C, et al. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol. 2001;22:624–9.PubMedCrossRef MacIntyre CR, Empson M, Boardman C, et al. Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol. 2001;22:624–9.PubMedCrossRef
20.
go back to reference Bonten MJ, Slaughter S, Ambergen AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158:1127–32.PubMedCrossRef Bonten MJ, Slaughter S, Ambergen AW, et al. The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med. 1998;158:1127–32.PubMedCrossRef
21.
go back to reference Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect. 2008;14:14–21.PubMedCrossRef Sakka V, Tsiodras S, Galani L, et al. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect. 2008;14:14–21.PubMedCrossRef
22.
go back to reference Ajao AO, Harris AD, Roghmann MC, et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol. 2011;32:481–9.PubMedCentralPubMedCrossRef Ajao AO, Harris AD, Roghmann MC, et al. Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Clostridium difficile acquisition. Infect Control Hosp Epidemiol. 2011;32:481–9.PubMedCentralPubMedCrossRef
23.
25.
go back to reference Liss BJ, Vehreschild JJ, Cornely OA, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2012;40:613–9.PubMedCrossRef Liss BJ, Vehreschild JJ, Cornely OA, et al. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection. 2012;40:613–9.PubMedCrossRef
Metadata
Title
Risk factors for enterococcal infection and colonization by vancomycin-resistant enterococci in critically ill patients
Authors
M. Papadimitriou-Olivgeris
E. Drougka
F. Fligou
F. Kolonitsiou
A. Liakopoulos
V. Dodou
E. D. Anastassiou
E. Petinaki
M. Marangos
K. S. Filos
I. Spiliopoulou
Publication date
01-12-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-014-0678-1

Other articles of this Issue 6/2014

Infection 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.